SGLT2 Inhibitors and Mechanisms of Hypertension

Briasoulis, Alexandros; Al Dhaybi, Omar; Bakris, George L.

doi:10.1007/s11886-018-0943-5

Record: found
Abstract: not found
Article: not found

SGLT2 Inhibitors and Mechanisms of Hypertension

Author(s): Alexandros Briasoulis , Omar Al Dhaybi , George L. Bakris

Publication date (Electronic): January 19 2018

Journal: Current Cardiology Reports

Publisher: Springer Science and Business Media LLC

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We sought to review currently available data on the safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 2 diabetes mellitus patients with hypertension.

Related collections

Author and article information

Journal

Title: Current Cardiology Reports

Abbreviated Title: Curr Cardiol Rep

Publisher: Springer Science and Business Media LLC

ISSN (Print): 1523-3782

ISSN (Electronic): 1534-3170

Publication date Created: January 2018

Publication date (Electronic): January 19 2018

Publication date (Print): January 2018

Volume: 20

Issue: 1

Article

DOI: 10.1007/s11886-018-0943-5

PubMed ID: 29349558

SO-VID: 7217a8d9-62d5-4f08-a7b9-af6fa3265f1b

License:

http://www.springer.com/tdm

History

Data availability:

Comments

Comment on this article

scite_

Cited by 33

See all cited by

- Version 1

SGLT2 Inhibitors and Mechanisms of Hypertension

Read this article at

Abstract

Related collections

ScienceOpen Research

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 5,323

Cited by 33